DESCRIPTION: (provided by the applicant): Deer mice (Peromyscus maniculatus)
are the natural reservoirs for Sin Nombre (SN) Hantavirus, the cause of an
often-fatal acute cardiorespiratory illness, Hantavirus cardiopulmonary
syndrome (HCPS). HCPS is most common in the western United States, with more
than 50 cases recorded in New Mexico alone. Minorities, especially American
Indians, and the poor are especially affected. Virtually nothing is known of
how SN virus is maintained in wild rodents, and thus it is very difficult to
predict outbreaks or to prevent spread of the virus in the wild. The virus is
spread among adult wild rodents and despite being locally extinct at times, it
dramatically increase to infect up to 50 percent of the mice in a population.
Deer mice develop lifelong infection after exposure, but after about 60 days
the virus is vastly diminished, with residual low levels of viral expression
can be found primarily in the heart, lungs, and brown adipose tissue (BAT). SN
virus has evolved some mysterious means by which it can reactivate in a
population in response to seasonal influences, and that reactivation leads to
spread among mice. Recently we found that cold stress may cause a reactivation
of viral infection in deer mice. This finding suggests that the virus may be
using the host?s normal stress response to support reactivation. To pursue this
further we propose to determine (1) how stress responses promote the
reactivation of hantaviruses in the laboratory; (2) what events cause
hantaviruses to reactivate in deer mice; and (3) the molecular interactions
that lead to the activation of the virus in infected cells and animals.
This study will open a new window of study of the mechanisms of maintenance of
persistent viral infections in populations, and will have special relevance to
zoonotic RNA virus diseases such as those caused by hantaviruses, arenaviruses
such as Lassa, Ebola virus and rabies virus.
National Institute of Allergy and Infectious Diseases
CFDA Code
856
DUNS Number
868853094
UEI
F6XLTRUQJEN4
Project Start Date
01-April-2002
Project End Date
31-March-2004
Budget Start Date
01-April-2002
Budget End Date
31-March-2004
Project Funding Information for 2002
Total Funding
$290,000
Direct Costs
$200,000
Indirect Costs
$90,000
Year
Funding IC
FY Total Cost by IC
2002
National Institute of Allergy and Infectious Diseases
$290,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R21AI050763-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R21AI050763-01
Patents
No Patents information available for 1R21AI050763-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R21AI050763-01
Clinical Studies
No Clinical Studies information available for 1R21AI050763-01
News and More
Related News Releases
No news release information available for 1R21AI050763-01
History
No Historical information available for 1R21AI050763-01
Similar Projects
No Similar Projects information available for 1R21AI050763-01